Here’s our pick of the most interesting research news this week: Protein engineering 👩🔬This review by scientists at Caltech (including Nobel Laureate Frances Arnold, a keynote speaker at SynBioBeta 2019) covers basic...
Author - Marianna Limas
Synthetic biology news from the lab bench #3
From more efficient CRISPR tools to (future) computers made with bacteria, it was another big week for synthetic biology research. Here’s the news you need to know: Agriculture 🌼Scientists have discovered a gene that...
Synthetic biology news from the lab bench #2
From molecular thumb drives and living computers to CRISPR to eliminate HIV, it was another big week for synthetic biology research. Here’s the news you need to know: Data storage 🧫DNA isn’t the only molecule we could...
Synthetic biology news from the lab bench #1
From living buildings and protein music to DNAzymes and biohybrid robots, it was another big week for synthetic biology research. Here’s the news you need to know: Environment 🏕Newcastle and Northumbria Universities...
“Biodesign Here Now” showcases the innovators designing a more sustainable future with biology
This week, I went to an amazing exhibition in London as part of SynbiTECH 2019, curated and organized by Open Cell (a 70 shipping container village in London supported by SynbiCITE, the UK’s synthetic biology industry...
How can you help shape U.S. science over the next decade? Here are some big ideas.
The National Science Foundation put out a call last fall for big ideas to inform its research agenda for the coming decade, and it received more than 800 submissions. Entries were judged and now 33 are in the running...
Roadmap encourages federal investment in synthetic biology research
This week, a group of more than 80 scientists and engineers from more than 30 universities and a dozen companies released a new, technical roadmap that lays out a path for achieving the promise of engineering biology...
Inscripta adds $20M to its $105M Series C to create CRISPR-powered gene editing tools
Gene editing company Inscripta’s vision is to “operationalize” biology with its CRISPR-powered tools. It got one step closer today with the announcement of $20M in additional Series C funding, bringing their Series C to...
Digest #253 – $1.2 billion in 1 week: Moderna $604M IPO, Zymergen $400M, Synthorx $131M IPO, Synthace $25.6M, Elemental Machines $9M, GenEdit $8.5M + our early bird ends Friday!
Your guide to what’s new in synthetic biology Hi all, It’s been a phenomenal week for the synthetic biology industry with $1.2B flowing into the industry from a couple of big IPOs and some big new funding...
News digest #252 – iGEM teams find success with lab automation and cell-free expression, tips for building your biotech startup team (12/5/2018)
Your guide to what’s new in synthetic biology Hi all, Synthetic biology is about to close out a record year, and 2019 promises to be even bigger. Are you hiring? We have a recruitment promotion on right...
